BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Batra A, Zeitz M, Siegmund B. Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1897-1905. [PMID: 19408337 DOI: 10.1002/ibd.20937] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Ribaldone DG, Pellicano R, Actis GC. Inflammation: a highly conserved, Janus-like phenomenon—a gastroenterologist’ perspective. J Mol Med 2018;96:861-71. [DOI: 10.1007/s00109-018-1668-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
2 Cañete F, Mañosa M, Clos A, Cabré E, Domènech E. Review article: the relationship between obesity, bariatric surgery, and inflammatory bowel disease. Aliment Pharmacol Ther 2018;48:807-16. [PMID: 30178869 DOI: 10.1111/apt.14956] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
3 He X, Wang WZ, Zhao CH, Sun JS, Wang LH. Significance of expression of adiponectin in patients with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2015; 23(12): 1999-2002 [DOI: 10.11569/wcjd.v23.i12.1999] [Reference Citation Analysis]
4 Dias CB, Milanski M, Portovedo M, Horita V, Ayrizono Mde L, Planell N, Coy CS, Velloso LA, Meirelles LR, Leal RF. Defective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patients. PLoS One 2014;9:e98547. [PMID: 24887376 DOI: 10.1371/journal.pone.0098547] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
5 Zareef R, Younis N, Mahfouz R. Inflammatory bowel disease: A key role for microbiota? Meta Gene 2020;25:100713. [DOI: 10.1016/j.mgene.2020.100713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ding Z, Wu X, Remer EM, Lian L, Stocchi L, Li Y, Mccullough A, Remzi FH, Shen B. Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery. Colorectal Dis 2016;18:163-72. [DOI: 10.1111/codi.13128] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
7 Le Dréan G, Haure-Mirande V, Ferrier L, Bonnet C, Hulin P, de Coppet P, Segain JP. Visceral adipose tissue and leptin increase colonic epithelial tight junction permeability via a RhoA-ROCK-dependent pathway. FASEB J 2014;28:1059-70. [PMID: 24243887 DOI: 10.1096/fj.13-234203] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
8 Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wójcik D, Magierowska K, Kwiecien S, Mach T, Brzozowski T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep 2016;68:827-36. [PMID: 27255494 DOI: 10.1016/j.pharep.2016.04.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
9 Rodrigues VS, Milanski M, Fagundes JJ, Torsoni AS, Ayrizono ML, Nunez CE, Dias CB, Meirelles LR, Dalal S, Coy CS. Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn’s disease. Clin Exp Immunol. 2012;170:358-364. [PMID: 23121676 DOI: 10.1111/j.1365-2249.2012.04660.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
10 Eder P, Adler M, Dobrowolska A, Kamhieh-Milz J, Witowski J. The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells 2019;8:E628. [PMID: 31234447 DOI: 10.3390/cells8060628] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
11 Feng Q, Xu XT, Zhou Y, Yan YQ, Ran ZH, Zhu J. Creeping fat in patients with ileo-colonic Crohn's disease correlates with disease activity and severity of inflammation: A preliminary study using energy spectral computed tomography. J Dig Dis 2018;19:475-84. [PMID: 30062772 DOI: 10.1111/1751-2980.12652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ge Y, Li Y, Gong J, Zhu W. Mesenteric organ lymphatics and inflammatory bowel disease. Ann Anat 2018;218:199-204. [PMID: 29723582 DOI: 10.1016/j.aanat.2018.03.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14:110-121. [PMID: 27899815 DOI: 10.1038/nrgastro.2016.181] [Cited by in Crossref: 163] [Cited by in F6Publishing: 139] [Article Influence: 27.2] [Reference Citation Analysis]
14 Janas RM, Rybak A, Wierzbicka-Rucińska A, Socha P, Śnitko R, Szaflarska-Popławska A, Stolarczyk A, Oralewska B, Cytra-Jarocka E, Iwańczak B, Grzybowska-Chlebowczyk U, Cichy W, Czaja-Bulsa G, Socha J. Serum Concentrations of Insulin, Ghrelin, Adiponectin, Leptin, Leptin Receptor and Lipocalin-2 in Children with Celiac Disease Who Do and Do Not Adhere to a Gluten-Free Diet. Gut Liver 2016;10:587-94. [PMID: 27074817 DOI: 10.5009/gnl15404] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
15 Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z, Pajdo R, Kwiecien S, Danielak A, Ptak-Belowska A, Brzozowski T. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.Biomolecules. 2019;9. [PMID: 31779136 DOI: 10.3390/biom9120780] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
16 Monk JM, Hou TY, Turk HF, Weeks B, Wu C, McMurray DN, Chapkin RS. Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis. PLoS One. 2012;7:e49739. [PMID: 23166761 DOI: 10.1371/journal.pone.0049739] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
17 Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, Saudemont A, Tachon M, Béclin E, Odou MF, Neut C, Colombel JF, Desreumaux P. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2012;61:78-85. [PMID: 21940721 DOI: 10.1136/gutjnl-2011-300370] [Cited by in Crossref: 163] [Cited by in F6Publishing: 152] [Article Influence: 16.3] [Reference Citation Analysis]
18 Mazur-Bialy AI, Bilski J, Wojcik D, Brzozowski B, Surmiak M, Hubalewska-Mazgaj M, Chmura A, Magierowski M, Magierowska K, Mach T, Brzozowski T. Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers. Nutrients. 2017;9. [PMID: 28425943 DOI: 10.3390/nu9040410] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
19 Ge Y, Li Y, Chen Q, Zhu W, Zuo L, Guo Z, Gong J, Cao L, Gu L, Li J. Adipokine apelin ameliorates chronic colitis in Il-10-/- mice by promoting intestinal lymphatic functions. Biochem Pharmacol. 2018;148:202-212. [PMID: 29309764 DOI: 10.1016/j.bcp.2018.01.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
20 Waluga M, Hartleb M, Boryczka G, Kukla M, Żwirska-Korczala K. Serum adipokines in inflammatory bowel disease. World J Gastroenterol 2014; 20(22): 6912-6917 [PMID: 24944482 DOI: 10.3748/wjg.v20.i22.6912] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
21 Li Y, Zuo L, Zhu W, Gong J, Zhang W, Guo Z, Gu L, Li N, Li J. Telmisartan attenuates the inflamed mesenteric adipose tissue in spontaneous colitis by mechanisms involving regulation of neurotensin/microRNA-155 pathway. Biochemical Pharmacology 2015;93:461-9. [DOI: 10.1016/j.bcp.2014.12.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
22 Batra A, Stroh T, Siegmund B. Extraluminal factors contributing to inflammatory bowel disease. World J Gastroenterol 2011; 17(5): 572-577 [PMID: 21350706 DOI: 10.3748/wjg.v17.i5.572] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
23 Batra A, Okur B, Glauben R, Erben U, Ihbe J, Stroh T, Fedke I, Chang HD, Zeitz M, Siegmund B. Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo. Endocrinology. 2010;151:56-62. [PMID: 19966187 DOI: 10.1210/en.2009-0565] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 5.8] [Reference Citation Analysis]
24 Michalak A, Mosińska P, Fichna J. Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives. Pharmacol Rep 2016;68:837-46. [PMID: 27238750 DOI: 10.1016/j.pharep.2016.04.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
25 Al-Hassi HO, Bernardo D, Murugananthan AU, Mann ER, English NR, Jones A, Kamm MA, Arebi N, Hart AL, Blakemore AI, Stagg AJ, Knight SC. A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease. Mucosal Immunol 2013;6:751-61. [PMID: 23168838 DOI: 10.1038/mi.2012.113] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
26 Theocharidou E, Balaska A, Vogiatzis K, Tellis CC, Gossios TD, Athyros VG, Tselepis AD, Karagiannis A. Hypertrophic Mesenteric Adipose Tissue May Play a Role in Atherogenesis in Inflammatory Bowel Diseases: . Inflammatory Bowel Diseases 2016;22:2206-12. [DOI: 10.1097/mib.0000000000000873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Bertin B, Desreumaux P, Dubuquoy L. Obesity, visceral fat and Crohn's disease. Curr Opin Clin Nutr Metab Care 2010;13:574-80. [PMID: 20625283 DOI: 10.1097/MCO.0b013e32833cf0f4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
28 Zhang J, Jin H, Zhu A, Ying R, Wei W, Zhang F. Prognostic significance of plasma chemerin levels in patients with gastric cancer. Peptides 2014;61:7-11. [DOI: 10.1016/j.peptides.2014.08.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
29 Kredel LI, Siegmund B. Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Front Immunol 2014;5:462. [PMID: 25309544 DOI: 10.3389/fimmu.2014.00462] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
30 Mao R, Kurada S, Gordon IO, Baker ME, Gandhi N, McDonald C, Coffey JC, Rieder F. The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease. Inflamm Bowel Dis. 2019;25:421-426. [PMID: 30346528 DOI: 10.1093/ibd/izy331] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 32.0] [Reference Citation Analysis]